Based on proxy statements from most of the firms in the GenomeWeb Daily News Index, CEO compensation for 2012 averaged more than $4.8 million, up from a little less than $4.5 million in 2011.
More than half of the firms in the GenomeWeb Daily News Index lowered their CEO compensation last year from 2008, but a small number of companies dramatically increased theirs, raising the overall average paid out by the companies to $4.3 million.
The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.
A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.
The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.
In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.